XTL Biopharmaceuticals logo

XTL Biopharmaceuticals

XTLB | NASDAQ
Chart Builder DCF Calculator
$1.54
-$0.06 (-3.75%)
At close: Nov 16, 2026, 4:00 PM ET
$1.56
+$0.02 (+1.30%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.75%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
24.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #949/1021 (Top 93%)

Key Statistics

Market Data

Market Cap $1.46M
1D Range
1.54 1.69
52W Range
1.53 4.28

Valuation (TTM)

PE -0.53
PB -5.74
EV/EBITDA -10.13

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to...

Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Sep 1, 2005
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.